文献速递乳腺癌放疗放疗物理与技术

全乳放疗后中重度晚期副作用的皮肤剂量体积预测因素

Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy.
PubMed 文献 · Radiother Oncol · 2024-02-27

该研究基于2009至2017年单中心1066例早期乳腺癌保乳术后接受切线野40 Gy/15次全乳放疗的患者,回顾性勾画皮肤结构并构建机器学习NTCP模型,预测放疗结束后42个月内发生FATP G≥2的中重度晚期副作用。FATP G2+发生率为3.8%(40/1066),最终选用包含术后美容改变(OR=7.3)、芳香化酶抑制剂(保护因素,OR=0.45)、V20 Gy(OR=1.02)和V42 Gy(OR=1.09)的四变量模型。

要点

  • 全乳40 Gy/15次放疗后42个月内FATP G≥2发生率为3.8%(40/1066)。
  • 术后美容改变OR=7.3,芳香化酶抑制剂为保护因素OR=0.45。
  • 皮肤V20 Gy(处方剂量50%)OR=1.02,V42 Gy(105%)OR=1.09。

核心结论

  • 量化了40 Gy/15次全乳放疗后晚期反应与皮肤DVH的关联,提示V20和V42具有独立作用。
  • 少数临床因素可大幅调节风险。

研究设计与样本

  • 回顾性单中心队列研究,纳入2009至2017年早期乳腺癌患者1066例。
  • 皮肤结构定义为CT体轮廓外5 mm内各向同性扩展,并进行回顾性勾画。
  • 患者接受切线野全乳放疗,处方剂量40 Gy/15次。
  • 采用SOMA/LENT评分在随访中记录毒性,终点为放疗结束后42个月内发生的FATP G≥2中重度晚期副作用。
  • 设计机器学习流程,以逻辑模型结合临床因素和皮肤绝对DVH(cc)参数作为输出。

主要发现

  • FATP G2+发生率为3.8%,1066例中40例出现副作用。
  • 变量预处理后采用交叉验证确定最佳性能模型。
  • 选用四变量模型:术后美容改变OR=7.3,芳香化酶抑制剂OR=0.45(保护因素),V20 Gy(处方剂量50%)OR=1.02,V42 Gy(105%)OR=1.09。
  • 各因素也被转换为校正后的V20 Gy。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Toxicity after whole breast Radiotherapy is a relevant issue, impacting the quality-of-life of a not negligible number of patients. We aimed to develop a Normal Tissue Complication Probability (NTCP) model predicting late toxicities by combining dosimetric parameters of the breast dermis and clinical factors. METHODS: The skin structure was defined as the outer CT body contour's 5 mm inner isotropic expansion. It was retrospectively segmented on a large mono-institutional cohort of early-stage breast cancer patients enrolled between 2009 and 2017 (n = 1066). Patients were treated with tangential-field RT, delivering 40 Gy in 15 fractions to the whole breast. Toxicity was reported during Follow-Up (FU) using SOMA/LENT scoring. The study endpoint was moderate-severe late side effects consisting of Fibrosis-Atrophy-Telangiectasia-Pain (FATP G ≥ 2) developed within 42 months after RT completion. A machine learning pipeline was designed with a logistic model combining clinical factors and absolute skin DVH (cc) parameters as output. RESULTS: The FATP G2 + rate was 3.8 %, with 40/1066 patients experiencing side effects. After the preprocessing of variables, a cross-validation was applied to define the best-performing model. We selected a 4-variable model with Post-Surgery Cosmetic alterations (Odds Ratio, OR = 7.3), Aromatase Inhibitors (as a protective factor with OR = 0.45), V20 Gy (50 % of the prescribed dose, OR = 1.02), and V42 Gy (105 %, OR = 1.09). Factors were also converted into an adjusted V20Gy. CONCLUSIONS: The association between late reactions and skin DVH when delivering 40 Gy/15 fr was quantified, suggesting an independent role of V20 and V42. Few clinical factors heavily modulate the risk.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Cicchetti A, Mangili P, Fodor A, et al. Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy. Radiother Oncol. 2024. PMID: 38423138. doi:10.1016/j.radonc.2024.110183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。